Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice.

Identifieur interne : 001743 ( PubMed/Corpus ); précédent : 001742; suivant : 001744

An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice.

Auteurs : Maria Rohm ; Michaela Sch Fer ; Victor Laurent ; Bilgen Ekim Üstünel ; Katharina Niopek ; Carolyn Algire ; Oksana Hautzinger ; Tjeerd P. Sijmonsma ; Annika Zota ; Dasa Medrikova ; Natalia S. Pellegata ; Mikael Ryden ; Agné Kulyte ; Ingrid Dahlman ; Peter Arner ; Natasa Petrovic ; Barbara Cannon ; Ez-Zoubir Amri ; Bruce E. Kemp ; Gregory R. Steinberg ; Petra Janovska ; Jan Kopecky ; Christian Wolfrum ; Matthias Blüher ; Mauricio Berriel Diaz ; Stephan Herzig

Source :

RBID : pubmed:27571348

English descriptors

Abstract

Cachexia represents a fatal energy-wasting syndrome in a large number of patients with cancer that mostly results in a pathological loss of skeletal muscle and adipose tissue. Here we show that tumor cell exposure and tumor growth in mice triggered a futile energy-wasting cycle in cultured white adipocytes and white adipose tissue (WAT), respectively. Although uncoupling protein 1 (Ucp1)-dependent thermogenesis was dispensable for tumor-induced body wasting, WAT from cachectic mice and tumor-cell-supernatant-treated adipocytes were consistently characterized by the simultaneous induction of both lipolytic and lipogenic pathways. Paradoxically, this was accompanied by an inactivated AMP-activated protein kinase (Ampk), which is normally activated in peripheral tissues during states of low cellular energy. Ampk inactivation correlated with its degradation and with upregulation of the Ampk-interacting protein Cidea. Therefore, we developed an Ampk-stabilizing peptide, ACIP, which was able to ameliorate WAT wasting in vitro and in vivo by shielding the Cidea-targeted interaction surface on Ampk. Thus, our data establish the Ucp1-independent remodeling of adipocyte lipid homeostasis as a key event in tumor-induced WAT wasting, and we propose the ACIP-dependent preservation of Ampk integrity in the WAT as a concept in future therapies for cachexia.

DOI: 10.1038/nm.4171
PubMed: 27571348

Links to Exploration step

pubmed:27571348

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice.</title>
<author>
<name sortKey="Rohm, Maria" sort="Rohm, Maria" uniqKey="Rohm M" first="Maria" last="Rohm">Maria Rohm</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sch Fer, Michaela" sort="Sch Fer, Michaela" uniqKey="Sch Fer M" first="Michaela" last="Sch Fer">Michaela Sch Fer</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Laurent, Victor" sort="Laurent, Victor" uniqKey="Laurent V" first="Victor" last="Laurent">Victor Laurent</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ustunel, Bilgen Ekim" sort="Ustunel, Bilgen Ekim" uniqKey="Ustunel B" first="Bilgen Ekim" last="Üstünel">Bilgen Ekim Üstünel</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Niopek, Katharina" sort="Niopek, Katharina" uniqKey="Niopek K" first="Katharina" last="Niopek">Katharina Niopek</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Algire, Carolyn" sort="Algire, Carolyn" uniqKey="Algire C" first="Carolyn" last="Algire">Carolyn Algire</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hautzinger, Oksana" sort="Hautzinger, Oksana" uniqKey="Hautzinger O" first="Oksana" last="Hautzinger">Oksana Hautzinger</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sijmonsma, Tjeerd P" sort="Sijmonsma, Tjeerd P" uniqKey="Sijmonsma T" first="Tjeerd P" last="Sijmonsma">Tjeerd P. Sijmonsma</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zota, Annika" sort="Zota, Annika" uniqKey="Zota A" first="Annika" last="Zota">Annika Zota</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Medrikova, Dasa" sort="Medrikova, Dasa" uniqKey="Medrikova D" first="Dasa" last="Medrikova">Dasa Medrikova</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Pellegata, Natalia S" sort="Pellegata, Natalia S" uniqKey="Pellegata N" first="Natalia S" last="Pellegata">Natalia S. Pellegata</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ryden, Mikael" sort="Ryden, Mikael" uniqKey="Ryden M" first="Mikael" last="Ryden">Mikael Ryden</name>
<affiliation>
<nlm:affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kulyte, Agne" sort="Kulyte, Agne" uniqKey="Kulyte A" first="Agné" last="Kulyte">Agné Kulyte</name>
<affiliation>
<nlm:affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dahlman, Ingrid" sort="Dahlman, Ingrid" uniqKey="Dahlman I" first="Ingrid" last="Dahlman">Ingrid Dahlman</name>
<affiliation>
<nlm:affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Arner, Peter" sort="Arner, Peter" uniqKey="Arner P" first="Peter" last="Arner">Peter Arner</name>
<affiliation>
<nlm:affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Petrovic, Natasa" sort="Petrovic, Natasa" uniqKey="Petrovic N" first="Natasa" last="Petrovic">Natasa Petrovic</name>
<affiliation>
<nlm:affiliation>Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cannon, Barbara" sort="Cannon, Barbara" uniqKey="Cannon B" first="Barbara" last="Cannon">Barbara Cannon</name>
<affiliation>
<nlm:affiliation>Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Amri, Ez Zoubir" sort="Amri, Ez Zoubir" uniqKey="Amri E" first="Ez-Zoubir" last="Amri">Ez-Zoubir Amri</name>
<affiliation>
<nlm:affiliation>Université Côte d'Azur, Nice, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kemp, Bruce E" sort="Kemp, Bruce E" uniqKey="Kemp B" first="Bruce E" last="Kemp">Bruce E. Kemp</name>
<affiliation>
<nlm:affiliation>St Vincent's Institute of Medical Research, University of Melbourne, Fitzroy, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Steinberg, Gregory R" sort="Steinberg, Gregory R" uniqKey="Steinberg G" first="Gregory R" last="Steinberg">Gregory R. Steinberg</name>
<affiliation>
<nlm:affiliation>Department of Medicine, Division of Endocrinology and Metabolism, McMaster University, Hamilton, Ontario, Canada.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Janovska, Petra" sort="Janovska, Petra" uniqKey="Janovska P" first="Petra" last="Janovska">Petra Janovska</name>
<affiliation>
<nlm:affiliation>Department of Adipose Tissue Biology, Institute of Physiology of the Academy of Sciences of the Czech Republic, Prague, Czech Republic.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kopecky, Jan" sort="Kopecky, Jan" uniqKey="Kopecky J" first="Jan" last="Kopecky">Jan Kopecky</name>
<affiliation>
<nlm:affiliation>Department of Adipose Tissue Biology, Institute of Physiology of the Academy of Sciences of the Czech Republic, Prague, Czech Republic.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wolfrum, Christian" sort="Wolfrum, Christian" uniqKey="Wolfrum C" first="Christian" last="Wolfrum">Christian Wolfrum</name>
<affiliation>
<nlm:affiliation>Swiss Federal Institute of Technology, Institute of Food Nutrition and Health, Schwerzenbach, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bluher, Matthias" sort="Bluher, Matthias" uniqKey="Bluher M" first="Matthias" last="Blüher">Matthias Blüher</name>
<affiliation>
<nlm:affiliation>Department of Medicine, University of Leipzig, Leipzig, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Berriel Diaz, Mauricio" sort="Berriel Diaz, Mauricio" uniqKey="Berriel Diaz M" first="Mauricio" last="Berriel Diaz">Mauricio Berriel Diaz</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Herzig, Stephan" sort="Herzig, Stephan" uniqKey="Herzig S" first="Stephan" last="Herzig">Stephan Herzig</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27571348</idno>
<idno type="pmid">27571348</idno>
<idno type="doi">10.1038/nm.4171</idno>
<idno type="wicri:Area/PubMed/Corpus">001743</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001743</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice.</title>
<author>
<name sortKey="Rohm, Maria" sort="Rohm, Maria" uniqKey="Rohm M" first="Maria" last="Rohm">Maria Rohm</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sch Fer, Michaela" sort="Sch Fer, Michaela" uniqKey="Sch Fer M" first="Michaela" last="Sch Fer">Michaela Sch Fer</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Laurent, Victor" sort="Laurent, Victor" uniqKey="Laurent V" first="Victor" last="Laurent">Victor Laurent</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ustunel, Bilgen Ekim" sort="Ustunel, Bilgen Ekim" uniqKey="Ustunel B" first="Bilgen Ekim" last="Üstünel">Bilgen Ekim Üstünel</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Niopek, Katharina" sort="Niopek, Katharina" uniqKey="Niopek K" first="Katharina" last="Niopek">Katharina Niopek</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Algire, Carolyn" sort="Algire, Carolyn" uniqKey="Algire C" first="Carolyn" last="Algire">Carolyn Algire</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hautzinger, Oksana" sort="Hautzinger, Oksana" uniqKey="Hautzinger O" first="Oksana" last="Hautzinger">Oksana Hautzinger</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sijmonsma, Tjeerd P" sort="Sijmonsma, Tjeerd P" uniqKey="Sijmonsma T" first="Tjeerd P" last="Sijmonsma">Tjeerd P. Sijmonsma</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zota, Annika" sort="Zota, Annika" uniqKey="Zota A" first="Annika" last="Zota">Annika Zota</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Medrikova, Dasa" sort="Medrikova, Dasa" uniqKey="Medrikova D" first="Dasa" last="Medrikova">Dasa Medrikova</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Pellegata, Natalia S" sort="Pellegata, Natalia S" uniqKey="Pellegata N" first="Natalia S" last="Pellegata">Natalia S. Pellegata</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ryden, Mikael" sort="Ryden, Mikael" uniqKey="Ryden M" first="Mikael" last="Ryden">Mikael Ryden</name>
<affiliation>
<nlm:affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kulyte, Agne" sort="Kulyte, Agne" uniqKey="Kulyte A" first="Agné" last="Kulyte">Agné Kulyte</name>
<affiliation>
<nlm:affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dahlman, Ingrid" sort="Dahlman, Ingrid" uniqKey="Dahlman I" first="Ingrid" last="Dahlman">Ingrid Dahlman</name>
<affiliation>
<nlm:affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Arner, Peter" sort="Arner, Peter" uniqKey="Arner P" first="Peter" last="Arner">Peter Arner</name>
<affiliation>
<nlm:affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Petrovic, Natasa" sort="Petrovic, Natasa" uniqKey="Petrovic N" first="Natasa" last="Petrovic">Natasa Petrovic</name>
<affiliation>
<nlm:affiliation>Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cannon, Barbara" sort="Cannon, Barbara" uniqKey="Cannon B" first="Barbara" last="Cannon">Barbara Cannon</name>
<affiliation>
<nlm:affiliation>Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Amri, Ez Zoubir" sort="Amri, Ez Zoubir" uniqKey="Amri E" first="Ez-Zoubir" last="Amri">Ez-Zoubir Amri</name>
<affiliation>
<nlm:affiliation>Université Côte d'Azur, Nice, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kemp, Bruce E" sort="Kemp, Bruce E" uniqKey="Kemp B" first="Bruce E" last="Kemp">Bruce E. Kemp</name>
<affiliation>
<nlm:affiliation>St Vincent's Institute of Medical Research, University of Melbourne, Fitzroy, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Steinberg, Gregory R" sort="Steinberg, Gregory R" uniqKey="Steinberg G" first="Gregory R" last="Steinberg">Gregory R. Steinberg</name>
<affiliation>
<nlm:affiliation>Department of Medicine, Division of Endocrinology and Metabolism, McMaster University, Hamilton, Ontario, Canada.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Janovska, Petra" sort="Janovska, Petra" uniqKey="Janovska P" first="Petra" last="Janovska">Petra Janovska</name>
<affiliation>
<nlm:affiliation>Department of Adipose Tissue Biology, Institute of Physiology of the Academy of Sciences of the Czech Republic, Prague, Czech Republic.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kopecky, Jan" sort="Kopecky, Jan" uniqKey="Kopecky J" first="Jan" last="Kopecky">Jan Kopecky</name>
<affiliation>
<nlm:affiliation>Department of Adipose Tissue Biology, Institute of Physiology of the Academy of Sciences of the Czech Republic, Prague, Czech Republic.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wolfrum, Christian" sort="Wolfrum, Christian" uniqKey="Wolfrum C" first="Christian" last="Wolfrum">Christian Wolfrum</name>
<affiliation>
<nlm:affiliation>Swiss Federal Institute of Technology, Institute of Food Nutrition and Health, Schwerzenbach, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bluher, Matthias" sort="Bluher, Matthias" uniqKey="Bluher M" first="Matthias" last="Blüher">Matthias Blüher</name>
<affiliation>
<nlm:affiliation>Department of Medicine, University of Leipzig, Leipzig, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Berriel Diaz, Mauricio" sort="Berriel Diaz, Mauricio" uniqKey="Berriel Diaz M" first="Mauricio" last="Berriel Diaz">Mauricio Berriel Diaz</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Herzig, Stephan" sort="Herzig, Stephan" uniqKey="Herzig S" first="Stephan" last="Herzig">Stephan Herzig</name>
<affiliation>
<nlm:affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Nature medicine</title>
<idno type="eISSN">1546-170X</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>AMP-Activated Protein Kinases (metabolism)</term>
<term>AMP-Activated Protein Kinases (pharmacology)</term>
<term>Adipocytes, White (drug effects)</term>
<term>Adipocytes, White (metabolism)</term>
<term>Adipose Tissue, White (drug effects)</term>
<term>Adipose Tissue, White (metabolism)</term>
<term>Animals</term>
<term>Apoptosis Regulatory Proteins (drug effects)</term>
<term>Apoptosis Regulatory Proteins (metabolism)</term>
<term>Cachexia (etiology)</term>
<term>Cachexia (metabolism)</term>
<term>Cells, Cultured</term>
<term>In Vitro Techniques</term>
<term>Lipid Metabolism (drug effects)</term>
<term>Lipogenesis (drug effects)</term>
<term>Lipolysis (drug effects)</term>
<term>Mice</term>
<term>Neoplasms (complications)</term>
<term>Neoplasms (metabolism)</term>
<term>Peptide Fragments (pharmacology)</term>
<term>Thermogenesis (drug effects)</term>
<term>Uncoupling Protein 1 (drug effects)</term>
<term>Uncoupling Protein 1 (metabolism)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en">
<term>Apoptosis Regulatory Proteins</term>
<term>Uncoupling Protein 1</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>AMP-Activated Protein Kinases</term>
<term>Apoptosis Regulatory Proteins</term>
<term>Uncoupling Protein 1</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>AMP-Activated Protein Kinases</term>
<term>Peptide Fragments</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Adipocytes, White</term>
<term>Adipose Tissue, White</term>
<term>Lipid Metabolism</term>
<term>Lipogenesis</term>
<term>Lipolysis</term>
<term>Thermogenesis</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Cachexia</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Adipocytes, White</term>
<term>Adipose Tissue, White</term>
<term>Cachexia</term>
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cells, Cultured</term>
<term>In Vitro Techniques</term>
<term>Mice</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Cachexia represents a fatal energy-wasting syndrome in a large number of patients with cancer that mostly results in a pathological loss of skeletal muscle and adipose tissue. Here we show that tumor cell exposure and tumor growth in mice triggered a futile energy-wasting cycle in cultured white adipocytes and white adipose tissue (WAT), respectively. Although uncoupling protein 1 (Ucp1)-dependent thermogenesis was dispensable for tumor-induced body wasting, WAT from cachectic mice and tumor-cell-supernatant-treated adipocytes were consistently characterized by the simultaneous induction of both lipolytic and lipogenic pathways. Paradoxically, this was accompanied by an inactivated AMP-activated protein kinase (Ampk), which is normally activated in peripheral tissues during states of low cellular energy. Ampk inactivation correlated with its degradation and with upregulation of the Ampk-interacting protein Cidea. Therefore, we developed an Ampk-stabilizing peptide, ACIP, which was able to ameliorate WAT wasting in vitro and in vivo by shielding the Cidea-targeted interaction surface on Ampk. Thus, our data establish the Ucp1-independent remodeling of adipocyte lipid homeostasis as a key event in tumor-induced WAT wasting, and we propose the ACIP-dependent preservation of Ampk integrity in the WAT as a concept in future therapies for cachexia.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">27571348</PMID>
<DateCreated>
<Year>2016</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>2017</Year>
<Month>08</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>11</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1546-170X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>22</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2016</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Nature medicine</Title>
<ISOAbbreviation>Nat. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice.</ArticleTitle>
<Pagination>
<MedlinePgn>1120-1130</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/nm.4171</ELocationID>
<Abstract>
<AbstractText>Cachexia represents a fatal energy-wasting syndrome in a large number of patients with cancer that mostly results in a pathological loss of skeletal muscle and adipose tissue. Here we show that tumor cell exposure and tumor growth in mice triggered a futile energy-wasting cycle in cultured white adipocytes and white adipose tissue (WAT), respectively. Although uncoupling protein 1 (Ucp1)-dependent thermogenesis was dispensable for tumor-induced body wasting, WAT from cachectic mice and tumor-cell-supernatant-treated adipocytes were consistently characterized by the simultaneous induction of both lipolytic and lipogenic pathways. Paradoxically, this was accompanied by an inactivated AMP-activated protein kinase (Ampk), which is normally activated in peripheral tissues during states of low cellular energy. Ampk inactivation correlated with its degradation and with upregulation of the Ampk-interacting protein Cidea. Therefore, we developed an Ampk-stabilizing peptide, ACIP, which was able to ameliorate WAT wasting in vitro and in vivo by shielding the Cidea-targeted interaction surface on Ampk. Thus, our data establish the Ucp1-independent remodeling of adipocyte lipid homeostasis as a key event in tumor-induced WAT wasting, and we propose the ACIP-dependent preservation of Ampk integrity in the WAT as a concept in future therapies for cachexia.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rohm</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schäfer</LastName>
<ForeName>Michaela</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Laurent</LastName>
<ForeName>Victor</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Üstünel</LastName>
<ForeName>Bilgen Ekim</ForeName>
<Initials>BE</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Niopek</LastName>
<ForeName>Katharina</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Algire</LastName>
<ForeName>Carolyn</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hautzinger</LastName>
<ForeName>Oksana</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sijmonsma</LastName>
<ForeName>Tjeerd P</ForeName>
<Initials>TP</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zota</LastName>
<ForeName>Annika</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Medrikova</LastName>
<ForeName>Dasa</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pellegata</LastName>
<ForeName>Natalia S</ForeName>
<Initials>NS</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ryden</LastName>
<ForeName>Mikael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kulyte</LastName>
<ForeName>Agné</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dahlman</LastName>
<ForeName>Ingrid</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arner</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Lipid Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Petrovic</LastName>
<ForeName>Natasa</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cannon</LastName>
<ForeName>Barbara</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Amri</LastName>
<ForeName>Ez-Zoubir</ForeName>
<Initials>EZ</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-8426-5396</Identifier>
<AffiliationInfo>
<Affiliation>Université Côte d'Azur, Nice, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Centre National de la Recherche Scientifique (CNRS), Nice, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kemp</LastName>
<ForeName>Bruce E</ForeName>
<Initials>BE</Initials>
<AffiliationInfo>
<Affiliation>St Vincent's Institute of Medical Research, University of Melbourne, Fitzroy, Victoria, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Mary MacKillop Institute for Health, Research Australian Catholic University, Melbourne, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Steinberg</LastName>
<ForeName>Gregory R</ForeName>
<Initials>GR</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Division of Endocrinology and Metabolism, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Janovska</LastName>
<ForeName>Petra</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Adipose Tissue Biology, Institute of Physiology of the Academy of Sciences of the Czech Republic, Prague, Czech Republic.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kopecky</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Adipose Tissue Biology, Institute of Physiology of the Academy of Sciences of the Czech Republic, Prague, Czech Republic.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wolfrum</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Swiss Federal Institute of Technology, Institute of Food Nutrition and Health, Schwerzenbach, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Blüher</LastName>
<ForeName>Matthias</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, University of Leipzig, Leipzig, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Berriel Diaz</LastName>
<ForeName>Mauricio</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Herzig</LastName>
<ForeName>Stephan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Deutsches Zentrum für Diabetesforschung, Neuherberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>08</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Nat Med</MedlineTA>
<NlmUniqueID>9502015</NlmUniqueID>
<ISSNLinking>1078-8956</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051017">Apoptosis Regulatory Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C112510">Cidea protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000604372">Ucp1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000071256">Uncoupling Protein 1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D055372">AMP-Activated Protein Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="C554549">Prkab1 protein, mouse</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Clin Nutr Metab Care. 2014 Nov;17(6):509-14</RefSource>
<PMID Version="1">25111867</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 1990 Nov;86(5):1403-8</RefSource>
<PMID Version="1">2243120</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cytokine. 2013 Feb;61(2):532-9</RefSource>
<PMID Version="1">23200412</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Med. 1980 Oct;69(4):491-7</RefSource>
<PMID Version="1">7424938</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Methods. 2011 Dec 28;9(1):57-63</RefSource>
<PMID Version="1">22205519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Cardiol. 2008 Jun 2;101(11A):8E-10E</RefSource>
<PMID Version="1">18514632</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes. 2005 Jun;54(6):1726-34</RefSource>
<PMID Version="1">15919794</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetologia. 2015 Apr;58(4):799-808</RefSource>
<PMID Version="1">25596852</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2011 Jul 8;333(6039):233-8</RefSource>
<PMID Version="1">21680814</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2014 Mar 25;9(3):e92966</RefSource>
<PMID Version="1">24667661</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Genet. 2003 Sep;35(1):49-56</RefSource>
<PMID Version="1">12910269</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Amino Acids. 2016 Aug;48(8):2015-24</RefSource>
<PMID Version="1">26781304</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Cardiol. 2008 Jan 1;101(1):8-14</RefSource>
<PMID Version="1">18157957</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes. 2010 Nov;59(11):2737-46</RefSource>
<PMID Version="1">20693347</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Nutr. 2013 Jan 28;109 (2):302-12</RefSource>
<PMID Version="1">23021109</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Lipid Res. 2009 Apr;50(4):704-15</RefSource>
<PMID Version="1">19050316</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2008 Sep;48(3):782-91</RefSource>
<PMID Version="1">18712775</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Metab. 2015 Nov 26;5(2):67-78</RefSource>
<PMID Version="1">26909315</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Mol Cell Biol. 2012 Mar 22;13(4):251-62</RefSource>
<PMID Version="1">22436748</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods. 2001 Dec;25(4):402-8</RefSource>
<PMID Version="1">11846609</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prog Mol Biol Transl Sci. 2010;94:39-74</RefSource>
<PMID Version="1">21036322</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2005 Jul 1;280(26):25250-7</RefSource>
<PMID Version="1">15878856</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods Mol Biol. 2000;99:63-74</RefSource>
<PMID Version="1">10909077</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 1989 Jun;3(8):1956-62</RefSource>
<PMID Version="1">2721856</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2008 Jun 13;283(24):16514-24</RefSource>
<PMID Version="1">18390901</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2013 Apr 2;17(4):575-85</RefSource>
<PMID Version="1">23499424</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nutr Cancer. 2015;67(1):12-26</RefSource>
<PMID Version="1">25513730</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Obesity (Silver Spring). 2009 Jul;17(7):1312-7</RefSource>
<PMID Version="1">19214174</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1962 Nov;237:3354-8</RefSource>
<PMID Version="1">13996476</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2010 Jan 1;285(1):115-22</RefSource>
<PMID Version="1">19892703</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 2005 May 27;96(10):1042-52</RefSource>
<PMID Version="1">15920027</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Physiol Scand. 1976 Sep;98(1):8-18</RefSource>
<PMID Version="1">970158</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1986 Sep 19;233(4770):1318-21</RefSource>
<PMID Version="1">3489291</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Tumour Biol. 2014 Sep;35(9):9291-301</RefSource>
<PMID Version="1">24938873</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Treat Options Oncol. 2010 Dec;11(3-4):107-17</RefSource>
<PMID Version="1">21128029</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Oncol. 2011 May;12(5):489-95</RefSource>
<PMID Version="1">21296615</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2012 Aug 8;16(2):153-66</RefSource>
<PMID Version="1">22795476</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2014 Sep 4;513(7516):100-4</RefSource>
<PMID Version="1">25043053</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 1994 Oct 10;353(1):33-6</RefSource>
<PMID Version="1">7926017</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Surgery. 2012 Sep;152(3 Suppl 1):S81-8</RefSource>
<PMID Version="1">22770957</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO Mol Med. 2013 Feb;5(2):294-308</RefSource>
<PMID Version="1">23307490</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Genet. 2006 Sep 15;2(9):e146</RefSource>
<PMID Version="1">17002498</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Crit Rev Oncol Hematol. 2011 Oct;80(1):114-44</RefSource>
<PMID Version="1">21216616</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2010 May 28;328(5982):1158-61</RefSource>
<PMID Version="1">20448152</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Cell Physiol. 2012 Dec 1;303(11):C1192-7</RefSource>
<PMID Version="1">23054058</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer. 2008 Oct 1;113(7):1695-704</RefSource>
<PMID Version="1">18704987</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arterioscler Thromb Vasc Biol. 2012 May;32(5):1094-8</RefSource>
<PMID Version="1">22517368</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lung Cancer. 2010 May;68(2):234-9</RefSource>
<PMID Version="1">19665818</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Cell Dev Biol. 2016 Jun;54:68-81</RefSource>
<PMID Version="1">26529279</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetologia. 2010 Apr;53(4):768-78</RefSource>
<PMID Version="1">20043143</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2008 Oct 17;135(2):240-9</RefSource>
<PMID Version="1">18835024</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2006 Dec;4(6):465-74</RefSource>
<PMID Version="1">17141630</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2013 Dec;19(12):1649-54</RefSource>
<PMID Version="1">24185692</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1997 May 1;387(6628):90-4</RefSource>
<PMID Version="1">9139827</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2007 Jun 1;67(11):5531-7</RefSource>
<PMID Version="1">17545636</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 1990 Apr 15;50(8):2290-5</RefSource>
<PMID Version="1">2317817</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2008 Nov 15;68(22):9247-54</RefSource>
<PMID Version="1">19010897</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Med. 2015 Dec 29;:null</RefSource>
<PMID Version="1">26736177</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2010 Jan 20;29(2):469-81</RefSource>
<PMID Version="1">19942859</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer. 1979 May;43(5 Suppl):2004-12</RefSource>
<PMID Version="1">376104</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Endocrinol Metab. 2011 Oct;301(4):E703-12</RefSource>
<PMID Version="1">21750268</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Metab. 2014 Sep 2;20(3):433-47</RefSource>
<PMID Version="1">25043816</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2008 Jun 4;27(11):1537-48</RefSource>
<PMID Version="1">18480843</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetologia. 2008 Oct;51(10):1893-900</RefSource>
<PMID Version="1">18709353</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D055372" MajorTopicYN="N">AMP-Activated Protein Kinases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D052438" MajorTopicYN="N">Adipocytes, White</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D052436" MajorTopicYN="N">Adipose Tissue, White</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051017" MajorTopicYN="N">Apoptosis Regulatory Proteins</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002100" MajorTopicYN="N">Cachexia</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D050155" MajorTopicYN="N">Lipogenesis</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008066" MajorTopicYN="N">Lipolysis</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D022722" MajorTopicYN="N">Thermogenesis</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000071256" MajorTopicYN="N">Uncoupling Protein 1</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>02</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2016</Year>
<Month>07</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>8</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>8</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>8</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27571348</ArticleId>
<ArticleId IdType="pii">nm.4171</ArticleId>
<ArticleId IdType="doi">10.1038/nm.4171</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001743 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001743 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:27571348
   |texte=   An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:27571348" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024